A recent study published in the Lancet determined the prevalence and treatment of diabetes among 141 million participants worldwide, from 175 countries.
In 2022, the prevalence was lowest (2-5%) in western Europe and east Africa. Highest (≥ 25%) in Polynesia and Micronesia, some Caribbean, Middle East, and north Africa countries, Pakistan, and Malaysia.
Although there is an overall improvement, the gap between the high-income western countries and pacific island nations, south Asian, and sub-Saharan Africa has increased in 2022. The coverage was 5-10% in sub-Saharan Africa countries like Burkina Faso, Angola, Niger, Liberia, and Benin. The highest treatment coverage 86% for women and 77% for men in Belgium.
More details on the article can be read here.